Jonathan Haverkampf

Prevalence of depression and its association with quality of life in patients after pacemaker implantation during the COVID-19 pandemic: A network analysis

This study was designed to investigate the prevalence of predictors of depression in patients after pacemaker implantation during the COVID-19 pandemic in addition to identifying specific depressive symptoms associated with quality of life (QOL) using network analysis (NA).

Prevalence of depression and its association with quality of life in patients after pacemaker implantation during the COVID-19 pandemic: A network analysis Read More »

Relationship of insight to neurocognitive function and risk of recurrence in depression: A naturalistic follow-up study

… Lack of insight may affect patients’ motivation to seek treatment, resulting in poor clinical outcomes. … Patients with MDD, without insight, had significantly higher total and factor scores (anxiety/somatization, weight, retardation, and sleep) on the HAM-D and worse performance in the neurocognition task, compared to those with insight. Furthermore, binary logistic regression revealed that

Relationship of insight to neurocognitive function and risk of recurrence in depression: A naturalistic follow-up study Read More »

Anxiety and Depression Are Tightly Linked: Why It Matters

Implications for prevention and treatment of depression and anxiety. Anxiety is present in over half of patients coping with depression. Some researchers and therapists believe depression and anxiety can be “different sides of the same coin.” Understanding the tight connection between anxiety and depression is important for preventing, diagnosing, and treating it.

Anxiety and Depression Are Tightly Linked: Why It Matters Read More »

Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials

To the Editor Hoge et al composed a well-written and interesting study examining the effect of mindfulness-based stress reduction (MBSR) vs escitalopram for the treatment of anxiety disorders. A prominent finding was that in adults with anxiety disorders, 8 weeks’ treatment with MBSR was noninferior to escitalopram.

Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials Read More »